What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review

Rogers, 2006, Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder, J Urol, 175, 2048, 10.1016/S0022-5347(06)00317-X Humphrey, 2016, The 2016 WHO classification of tumours of the urinary system and male genital organs—part B: prostate and bladder tumours, Eur Urol, 70, 106, 10.1016/j.eururo.2016.02.028 Chalasani, 2009, Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer, Can Urol Assoc J, 3, 193 Black, 2009, The impact of variant histology on the outcome of bladder cancer treated with curative intent, Urol Oncol, 27, 3, 10.1016/j.urolonc.2007.07.010 Mantica, 2018, The pathologist’s role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detection, Minerva Urol Nefrol, 70, 594, 10.23736/S0393-2249.18.03175-2 Lopez-Beltran, 2017, Variants of bladder cancer: the pathologist’s point of view, Eur Urol Suppl, 16, 210, 10.1016/j.eursup.2017.09.004 Compérat, 2018, A practical guide to bladder cancer pathology, Nat Rev Urol, 15, 143, 10.1038/nrurol.2018.2 Moher, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev, 4, 1, 10.1186/2046-4053-4-1 Veskimäe, 2018, What is the importance of urothelial and non-urothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? Hayden, 2013, Assessing bias in studies of prognostic factors, Ann Intern Med, 158, 280, 10.7326/0003-4819-158-4-201302190-00009 Jue, 2018, Sociodemographic and survival disparities for histologic variants of bladder cancer, Can J Urol, 25, 9179 Royce, 2018, Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: results from the National Cancer data Base, Urol Oncol, 36, 10.1016/j.urolonc.2017.10.013 Vetterlein, 2017, Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology: neoadjuvant CTX and bladder cancer variants, Cancer, 123, 4346, 10.1002/cncr.30907 Patel, 2018, Oncologic outcomes in patients with nonurothelial bladder cancer, Indian J Urol, 34, 39, 10.4103/iju.IJU_115_17 Abdel-Rahman, 2017, Squamous cell carcinoma of the bladder: a SEER database analysis, Clin Genitourin Cancer, 15, e463, 10.1016/j.clgc.2016.10.007 Chen, 2017, The prognostic value of histological subtype in patients with metastatic bladder cancer, Oncotarget, 8, 28408, 10.18632/oncotarget.16083 Moschini, 2017, Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy, Urol Oncol, 35, 335, 10.1016/j.urolonc.2016.12.006 Martin, 2018, Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort, World J Urol, 36, 1835, 10.1007/s00345-018-2331-6 Li, 2019, The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy, Eur Urol Focus, 5, 104, 10.1016/j.euf.2017.06.013 Wang, 2018, Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases, Hum Pathol, 79, 57, 10.1016/j.humpath.2018.05.005 Niu, 2018, Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study, Cancer Manag Res, 10, 4479, 10.2147/CMAR.S175286 Fernández, 2017, Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer, BJU Int, 119, 684, 10.1111/bju.13689 Sui, 2016, Micropapillary bladder cancer: insights from the National Cancer database, Bladder Cancer, 2, 415, 10.3233/BLC-160066 Izard, 2015, Outcomes of squamous histology in bladder cancer: a population-based study, Urol Oncol, 33, 10.1016/j.urolonc.2015.06.011 Kaushik, 2015, Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder: small cell carcinoma of the bladder, Int J Urol, 22, 549, 10.1111/iju.12729 Monn, 2015, Contemporary bladder cancer: variant histology may be a significant driver of disease, Urol Oncol, 33, 10.1016/j.urolonc.2014.10.001 Yang, 2015, Does squamous differentiation portend worse outcomes in urothelial bladder cancer?, Urol Pract, 2, 335, 10.1016/j.urpr.2015.02.003 Mitra, 2014, Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis, Urol Oncol, 32, 117, 10.1016/j.urolonc.2012.08.017 Beltran, 2014, Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder, Virchows Arch, 465, 199, 10.1007/s00428-014-1601-y Linder, 2013, Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis, J Urol, 189, 1670, 10.1016/j.juro.2012.11.006 Balci, 2013, Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?, World J Urol, 31, 1177, 10.1007/s00345-012-0872-7 Lynch, 2013, Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer center, Eur Urol, 64, 307, 10.1016/j.eururo.2012.04.020 Xylinas, 2013, Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy, Eur J Cancer, 49, 1889, 10.1016/j.ejca.2013.02.001 Wang, 2012, Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis, World J Urol, 30, 801, 10.1007/s00345-012-0976-0 Kim, 2012, The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma, J Urol, 188, 405, 10.1016/j.juro.2012.04.020 Ehdaie, 2012, Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy, J Urol, 187, 74, 10.1016/j.juro.2011.09.056 Scosyrev, 2011, BJU Int, 108, 693, 10.1111/j.1464-410X.2011.10582.x Wright, 2007, Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder, J Urol, 178, 2302, 10.1016/j.juro.2007.08.038 Davaro, 2019, Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer database, World J Urol, 37, 497, 10.1007/s00345-018-2411-7 Sui, 2017, Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer, World J Urol, 35, 1055, 10.1007/s00345-016-1962-8 Compérat, 2010, Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases, Pathology, 42, 650, 10.3109/00313025.2010.522173 Kamat, 2007, Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients, Cancer, 110, 62, 10.1002/cncr.22756 van der Zwan, 2018, Extra-pulmonary neuroendocrine carcinomas: a population-based study in the Netherlands, Neuroendocrinology, 107, 50, 10.1159/000488987 van de Kamp, 2018, Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: characteristics, treatment, and outcome, Urol Oncol, 36, 10.1016/j.urolonc.2018.02.015 Wu, 2018, Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis, Expert Rev Gastroenterol Hepatol, 12, 209, 10.1080/17474124.2018.1416291 Pasquier, 2015, Small cell carcinoma of the urinary bladder: a retrospective, multicenter Rare Cancer network study of 107 patients, Int J Radiat Oncol Biol Phys, 92, 904, 10.1016/j.ijrobp.2015.03.019 Guo, 2013, Clinicopathological characteristics and prognosis of Chinese patients with sarcomatoid carcinoma of the bladder, Histol Histopathol, 28, 1167 Wang, 2011, Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder, Urol Int, 86, 453, 10.1159/000324263 Wang, 2010, Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases, Sarcoma, 2010, 1, 10.1155/2010/454792 Zaghloul, 2006, Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients, Urol Oncol, 24, 13, 10.1016/j.urolonc.2005.05.027 Cheng, 2004, Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients, Cancer, 101, 957, 10.1002/cncr.20456 Hansel, 2013, A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens, Eur Urol, 63, 321, 10.1016/j.eururo.2012.10.008 Cai, 2014, Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens, Urology, 84, 1141, 10.1016/j.urology.2014.06.032 Wasco, 2007, Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection, Urology, 70, 69, 10.1016/j.urology.2007.03.033 Warrick, 2019, Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants, Eur Urol, 75, 18, 10.1016/j.eururo.2018.09.003 Pons, 2011, Variant forms of bladder cancer: basic considerations on treatment approaches, Curr Oncol Rep, 13, 216, 10.1007/s11912-011-0161-4 Berg, 2019, Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter?, Cancer, 125, 1449, 10.1002/cncr.31952 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097